Return On Assets of Tvardi Therapeutics, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Tvardi Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Tvardi Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -166%, a 188% decline year-over-year.
  • Tvardi Therapeutics, Inc. annual Return On Assets for 2024 was -114%, a 27% decline from 2023.
  • Tvardi Therapeutics, Inc. annual Return On Assets for 2023 was -90%, a 122% decline from 2022.
  • Tvardi Therapeutics, Inc. annual Return On Assets for 2022 was -40%, a 7.8% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -166% -108% -188% 01 Jul 2025 30 Sep 2025
Q2 2025 -154% -83% -117% 01 Apr 2025 30 Jun 2025
Q1 2025 -154% -72% -87% 01 Jan 2025 31 Mar 2025
Q4 2024 -114% -24% -27% 01 Oct 2024 31 Dec 2024
Q3 2024 -58% +22% +28% 01 Jul 2024 30 Sep 2024
Q2 2024 -71% -5.5% -8.4% 01 Apr 2024 30 Jun 2024
Q1 2024 -82% -39% -90% 01 Jan 2024 31 Mar 2024
Q4 2023 -90% -49% -122% 01 Oct 2023 31 Dec 2023
Q3 2023 -80% -41% -105% 01 Jul 2023 30 Sep 2023
Q2 2023 -65% -37% -127% 01 Apr 2023 30 Jun 2023
Q1 2023 -44% -3% -7.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -40% -2.9% -7.8% 01 Oct 2022 31 Dec 2022
Q3 2022 -39% -49% -494% 01 Jul 2022 30 Sep 2022
Q2 2022 -29% -33% -866% 01 Apr 2022 30 Jun 2022
Q1 2022 -40% -47% -704% 01 Jan 2022 31 Mar 2022
Q4 2021 -37% -42% -973% 01 Oct 2021 31 Dec 2021
Q3 2021 9.9% +63% 01 Jul 2021 30 Sep 2021
Q2 2021 3.8% +57% 01 Apr 2021 30 Jun 2021
Q1 2021 6.7% +61% 01 Jan 2021 31 Mar 2021
Q4 2020 4.3% +56% 01 Oct 2020 31 Dec 2020
Q3 2020 -53% -2.4% -4.8% 01 Jul 2020 30 Sep 2020
Q2 2020 -54% -6.6% -14% 01 Apr 2020 30 Jun 2020
Q1 2020 -54% -9.4% -21% 01 Jan 2020 31 Mar 2020
Q4 2019 -52% -4.6% -9.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -51% +0.14% +0.28% 01 Jul 2019 30 Sep 2019
Q2 2019 -47% +10% +18% 01 Apr 2019 30 Jun 2019
Q1 2019 -44% +7.8% +15% 01 Jan 2019 31 Mar 2019
Q4 2018 -47% +16% +25% 01 Oct 2018 31 Dec 2018
Q3 2018 -51% +28% +36% 01 Jul 2018 30 Sep 2018
Q2 2018 -57% +28% +33% 01 Apr 2018 30 Jun 2018
Q1 2018 -52% +46% +47% 01 Jan 2018 31 Mar 2018
Q4 2017 -63% +4.3% +6.4% 01 Oct 2017 31 Dec 2017
Q3 2017 -79% -33% -70% 01 Jul 2017 30 Sep 2017
Q2 2017 -85% -49% -136% 01 Apr 2017 30 Jun 2017
Q1 2017 -99% -66% -203% 01 Jan 2017 31 Mar 2017
Q4 2016 -68% -38% -124% 01 Oct 2016 31 Dec 2016
Q3 2016 -47% -18% -64% 01 Jul 2016 30 Sep 2016
Q2 2016 -36% +3% +7.6% 01 Apr 2016 30 Jun 2016
Q1 2016 -33% -0.55% -1.7% 01 Jan 2016 31 Mar 2016
Q4 2015 -30% -2.7% -9.9% 01 Oct 2015 31 Dec 2015
Q3 2015 -28% +0.02% +0.07% 01 Jul 2015 30 Sep 2015
Q2 2015 -39% 01 Apr 2015 30 Jun 2015
Q1 2015 -32% 01 Jan 2015 31 Mar 2015
Q4 2014 -28% 01 Oct 2014 31 Dec 2014
Q3 2014 -28% 01 Jul 2014 30 Sep 2014

Tvardi Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -114% -24% -27% 01 Jan 2024 31 Dec 2024
2023 -90% -49% -122% 01 Jan 2023 31 Dec 2023
2022 -40% -2.9% -7.8% 01 Jan 2022 31 Dec 2022
2021 -37% -42% -973% 01 Jan 2021 31 Dec 2021
2020 4.3% +56% 01 Jan 2020 31 Dec 2020
2019 -52% -4.6% -9.8% 01 Jan 2019 31 Dec 2019
2018 -47% +16% +25% 01 Jan 2018 31 Dec 2018
2017 -63% +4.3% +6.4% 01 Jan 2017 31 Dec 2017
2016 -68% -38% -124% 01 Jan 2016 31 Dec 2016
2015 -30% -2.7% -9.9% 01 Jan 2015 31 Dec 2015
2014 -28% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.